This report was recently updated on November 16 2024 with the latest and most recent
market numbers
Global Albumin and Creatinine Tests Market Size, Trends & Analysis - Forecasts to 2026 By Product (Dipsticks &Kits, Analyzers, Cartridges, Reagents & Other Consumables), By Type (Urine Tests, Blood & Serum Creatinine Tests), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Research Laboratories & Institutes), By Region (North America, Asia Pacific, Europe, Central & South America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis
The risk of kidney failure and diseases are rising globally. The delay in diagnosis of kidney diseases and busy lifestyles are putting people at the risk of increasing chronic diseases. The need for albumin tests for the CKD then plays an even important role and leads to high market valuation. The research findings in the past few years have pointed out the rising incidence of non-communicable diseases which creates an increasing incidence of CKD. Globally, 850 million individuals are affected by kidney disease emerging from numerous causes. The disease is more common in society and a large number of kidney disease/failure cases are not registered. The impact of the rising kidney disease creates room for campaign and awareness programs backed by medical associations and foundations. Dialysis is becoming a routine lifestyle and the need for routine tests increases creating more market opportunities.
The diagnosis is important to get the grip of the lifestyle disorders and make products and tests that are affordable and time-saving as per the patient’s needs.
The tests help in detecting kidney disease (mostly in individuals suffering from hypertension and diabetes) at an early stage and also detects the level of albumin present in the urine. As lifestyle changes and the world faces a rising prevalence of chronic diseases-hypertension and diabetes, the implication of CKD rises. Hypertension is becoming a common norm in the United States and around 972 million people globally suffer from hypertension (2019 data) and the estimates are expected to increase by 2025.
The ACR test is also experiencing technological changes as products are developed for home use. Healthy.io is one such product developed to conduct the ACR ratio and is a smartphone-based test designed for home use. Another technological change that has affected the market performance is the Albumin Tester. The product’s efficacy is supported by its simplicity, low cost, and rapid conduction of tests for routine use. The product also holds the potential to be successful in developed and developing regions.
The success of the market lies with the ongoing or past developments in the way body check up tests are conducted. Startups are creating affordable test kits that would perform 8 body tests either using blood or urine. The consistent practices of developing such products depend upon the fast regulatory approvals and support from the medical society. FDA’s increasing role in this market also has added benefits for the market to grow. Companies operating in developing affordable tests are more inclined towards the use of smartphones and software in conducting tests. The penetration of smartphones in this market space also leads to rising investment by the software and app development companies. In this space, Healthy-IO raised $60 million for its smartphone-based screening of tests.
The use of the software and devices that perform the BP and blood tests are gaining importance and due to the restricted visit to the hospitals in the wake of the COVID-19 pandemic, the shift towards home-based tests increased, and the use of digital BP machines also increased. The shift leads to increased awareness among individuals regarding the routine basic test and also among manufactures to develop new and advanced monitoring systems. The rising needs of the laboratories have pushed the manufacturers to update their product portfolio. The screening tests are also experiencing new data management features and increased operability. AAKRAY has been active in launching advanced features to its screening tools.
The market’s development is also impacted by the expansion and increased production capacity of the businesses producing diabetes testing equipment and diagnostic reagents. The advancements in the products like urine analyzer also have a significant impact on the market demand.
Dipsticks and kits would hold a major market portion as they are widely accepted and used to carry out tests and screen for albuminuria. The wide acceptance of the tests is due to the low costs it offers as a screening tool.
The cartridge as a screening tool will witness an upward rising trend as the manufacturers of the product are developing new tests and launching it at a rapid rate. The new ACR cartridge conduct accurate inspection of the urine and is used as an indicator for early diagnosis of renal failure.
Urine Tests are calculated to be a much efficient and better tool for the detection of kidney diseases. The test is widely preferred as it is non-invasive and provides fast results. The test is affordable and is recommended by the medical associations as well.
Diagnostic laboratories’ high growth in the market domain is due to the rising number of tests conducted every year. As India climbs the rocky path of the rising number of chronic diseases, the importance of blood tests, BP tests, and urine test also increase. This rise in the test also leads to an expansion in the test conducting capacity for the laboratories. COVID-19 as a driver led to the establishment of new laboratories across regions.
Hospitals and Clinics sustained dominating position is the result of huge budget allocations set for hospitals and the government’s innovative policy design aiding hospitals in screening for hypertension.
North America’s dominance in the market is due to the rising incidence of CKD and diagnostic testing. The government and medical society of the USA are also engaging in spreading awareness about chronic diseases and their impact on the lifestyle.
Asia Pacific’s rising capacity of laboratories to conduct tests and rise in the number of people suffering from hypertension places the region’s market in the limelight. Countries like India are seeking to expand laboratory testing and setting up new diagnostic labs to support the number of blood tests and BP tests conducted.
Roche Diagnostics, I-Sens, Siemens Healthineers, LabCorp, Healthy-IO, Nova Biomedical, ARKRAY Inc, and Bio-Rad are key players in this market.
Please note: This is not an exhaustive list of companies profiled in the report.
In February 2018, ARKRAY launched new reagent strips to measure lifestyle-based diseases and renal functions.
In September 2017, ARKRAY launched the urine analyser (fully automatic) equipped with new functions and features.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Albumin and Creatinine Tests Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Albumin and Creatinine Tests Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
